WO2009075329A1 - Composition gélatineuse dont l'aptitude à se dégrader est contrôlée - Google Patents

Composition gélatineuse dont l'aptitude à se dégrader est contrôlée Download PDF

Info

Publication number
WO2009075329A1
WO2009075329A1 PCT/JP2008/072526 JP2008072526W WO2009075329A1 WO 2009075329 A1 WO2009075329 A1 WO 2009075329A1 JP 2008072526 W JP2008072526 W JP 2008072526W WO 2009075329 A1 WO2009075329 A1 WO 2009075329A1
Authority
WO
WIPO (PCT)
Prior art keywords
gelatin composition
controlled degradability
gelatin
degradability
controlled
Prior art date
Application number
PCT/JP2008/072526
Other languages
English (en)
Japanese (ja)
Inventor
Shouji Ooya
Original Assignee
Fujifilm Corporation
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fujifilm Corporation filed Critical Fujifilm Corporation
Publication of WO2009075329A1 publication Critical patent/WO2009075329A1/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/78—Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin or cold insoluble globulin [CIG]
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08L—COMPOSITIONS OF MACROMOLECULAR COMPOUNDS
    • C08L89/00—Compositions of proteins; Compositions of derivatives thereof

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Polymers & Plastics (AREA)
  • Detergent Compositions (AREA)
  • Cosmetics (AREA)

Abstract

L'invention vise à proposer une composition gélatineuse dont l'aptitude à se dégrader est contrôlée. C'est-à-dire, l'invention propose une composition gélatineuse contenant au moins deux types de gélatine de types différents, caractérisée par le fait qu'au moins un type des gélatines décrites ci-dessus est un type de gélatine génétiquement modifiée.
PCT/JP2008/072526 2007-12-11 2008-12-11 Composition gélatineuse dont l'aptitude à se dégrader est contrôlée WO2009075329A1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2007319623 2007-12-11
JP2007-319623 2007-12-11

Publications (1)

Publication Number Publication Date
WO2009075329A1 true WO2009075329A1 (fr) 2009-06-18

Family

ID=40755568

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/JP2008/072526 WO2009075329A1 (fr) 2007-12-11 2008-12-11 Composition gélatineuse dont l'aptitude à se dégrader est contrôlée

Country Status (1)

Country Link
WO (1) WO2009075329A1 (fr)

Cited By (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2012046717A1 (fr) * 2010-10-05 2012-04-12 独立行政法人物質・材料研究機構 Adhésif tissulaire à deux composants et procédé de production de celui-ci
JP2013515128A (ja) * 2009-12-22 2013-05-02 ライフボンド リミテッド 架橋マトリックスの特性を調節するための酵素的架橋剤の改変
WO2014126222A1 (fr) * 2013-02-15 2014-08-21 国立大学法人高知大学 Sensibilisateur au rayonnement/chimiothérapie à utiliser pour une injection locale intratumorale et pour la libération contrôlée de peroxyde d'hydrogène ayant un hydrogel comme support
CN107016240A (zh) * 2017-04-05 2017-08-04 江西中医药大学 基于趋势平衡遗传算法的中药材勾兑优化方法
US10219997B2 (en) 2006-09-22 2019-03-05 Kochi University Radiation sensitizer or anti-cancer chemotherapy sensitizer
US11998654B2 (en) 2019-07-11 2024-06-04 Bard Shannon Limited Securing implants and medical devices

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH11338090A (ja) * 1997-12-24 1999-12-10 Fuji Photo Film Bv 写真応用に適した組換コラ―ゲンを有するハロゲン化銀乳剤及びその調製
JP2003516730A (ja) * 1999-11-12 2003-05-20 ファイブローゲン、インコーポレーテッド 組換えゼラチン
WO2004085473A2 (fr) * 2003-03-28 2004-10-07 Fuji Photo Film B.V. Proteines de type enrichi de rgd (arginine-glycine-acide aspartique) a liaison cellulaire amelioree
JP2007523047A (ja) * 2003-08-01 2007-08-16 ファイブローゲン、インコーポレーテッド ゼラチンカプセル

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH11338090A (ja) * 1997-12-24 1999-12-10 Fuji Photo Film Bv 写真応用に適した組換コラ―ゲンを有するハロゲン化銀乳剤及びその調製
JP2003516730A (ja) * 1999-11-12 2003-05-20 ファイブローゲン、インコーポレーテッド 組換えゼラチン
WO2004085473A2 (fr) * 2003-03-28 2004-10-07 Fuji Photo Film B.V. Proteines de type enrichi de rgd (arginine-glycine-acide aspartique) a liaison cellulaire amelioree
JP2007523047A (ja) * 2003-08-01 2007-08-16 ファイブローゲン、インコーポレーテッド ゼラチンカプセル

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
SUTTER M. ET AL.: "Recombinant gelatin hydrogels for the sustained release of proteins", JOURNAL OF CONTROLLED RELEASE, vol. 119, no. 3, 22 June 2007 (2007-06-22), pages 301 - 312 *

Cited By (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10758477B2 (en) 2006-09-22 2020-09-01 Yasuhiro Ogawa Radiation sensitizer or anti-cancer chemotherapy sensitizer
US10512604B2 (en) 2006-09-22 2019-12-24 Yasuhiro Ogawa Radiation sensitizer or anti-cancer chemotherapy sensitizer
US10219997B2 (en) 2006-09-22 2019-03-05 Kochi University Radiation sensitizer or anti-cancer chemotherapy sensitizer
US10202585B2 (en) 2009-12-22 2019-02-12 Lifebond Ltd Modification of enzymatic crosslinkers for controlling properties of crosslinked matrices
JP2013515128A (ja) * 2009-12-22 2013-05-02 ライフボンド リミテッド 架橋マトリックスの特性を調節するための酵素的架橋剤の改変
US9066991B2 (en) 2009-12-22 2015-06-30 Lifebond Ltd. Modification of enzymatic crosslinkers for controlling properties of crosslinked matrices
JP5594633B2 (ja) * 2010-10-05 2014-09-24 独立行政法人物質・材料研究機構 ２成分系組織接着剤及びその製造方法
US9499728B2 (en) 2010-10-05 2016-11-22 National Institute For Materials Science Two-component tissue adhesive and method for producing same
WO2012046717A1 (fr) * 2010-10-05 2012-04-12 独立行政法人物質・材料研究機構 Adhésif tissulaire à deux composants et procédé de production de celui-ci
JPWO2014126222A1 (ja) * 2013-02-15 2017-02-02 国立大学法人高知大学 ハイドロゲルを担体として過酸化水素を徐放する腫瘍内局注用の放射線／化学療法増感剤
WO2014126222A1 (fr) * 2013-02-15 2014-08-21 国立大学法人高知大学 Sensibilisateur au rayonnement/chimiothérapie à utiliser pour une injection locale intratumorale et pour la libération contrôlée de peroxyde d'hydrogène ayant un hydrogel comme support
CN107016240A (zh) * 2017-04-05 2017-08-04 江西中医药大学 基于趋势平衡遗传算法的中药材勾兑优化方法
CN107016240B (zh) * 2017-04-05 2020-01-24 江西中医药大学 基于趋势平衡遗传算法的中药材勾兑优化方法
US11998654B2 (en) 2019-07-11 2024-06-04 Bard Shannon Limited Securing implants and medical devices

Similar Documents

Publication Publication Date Title
EP2046108A4 (fr) Modification de la composition des acides gras du riz
IL204621A0 (en) Bicyclic - ?? - amino acid derivatives, compositions comprising the same and uses thereof
EP2221325A4 (fr) Composition photochrome durcissable
EP2209626A4 (fr) Composition multicouche colorée à réflectivité solaire élevée
WO2008025819A3 (fr) Formulations de l'acide acétylsalicylique ou de ses dérivés dans des capsules molles, présentant une stabilité élevée
CY1112122T1 (el) Συνθεση σφαιριδιου λιποϊκου οξεος
WO2009075329A1 (fr) Composition gélatineuse dont l'aptitude à se dégrader est contrôlée
BRPI0914940A8 (pt) Composições nutritivas contendo punicalaginas
BRPI1012249A2 (pt) "composto de cromeno tendo uma estrutura, composição fotocrômica curável, artigo óptico,e, composto de naftol".
WO2006113778A3 (fr) Compositions thermochromiques activees au laser
MX2009006479A (es) Derivados de hemicelulosa y estructuras que los emplean.
WO2013050944A3 (fr) Composition
WO2008090850A1 (fr) Agent pour améliorer l'effet d'un agent anti-cancer
AU2008336511B2 (en) Photochromic curable composition
AU2006903810A0 (en) Altering the fatty acid composition of rice
TH91212B (th) เครื่องเล่นแผ่นดิสก์เชิงแสง
TH84707B (th) สร้อยคอ
WO2008074655A3 (fr) Culot d'ampoule et ampoule
AU2006906647A0 (en) Plants with increased hexose content
TH87607B (th) ชิ้นส่วนสิ่งก่อสร้าง
TH88035B (th) แท่นปั๊มนูน
AU2006902470A0 (en) The town planner ref to PL 2002, No 2005901084, PL 1996
AU2006901792A0 (en) The fish hooka . new submission
TH84937B (th) ป้ายบอกผลิตภัณฑ์
AU2006902045A0 (en) V.L.T.D. virtual learn to drive

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 08859831

Country of ref document: EP

Kind code of ref document: A1

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 08859831

Country of ref document: EP

Kind code of ref document: A1

NENP Non-entry into the national phase

Ref country code: JP